SuperSonic Imagine logo — Innovations in Ultrasound.

SuperSonic Imagine

Innovations in Ultrasound.

Founded 2005 France France 165 employees Post-IPO Equity Total: $111.50M Biotechnology, Health Care +2

General Information

Company Name SuperSonic Imagine
Founded Year 2005
Location France France
Employees 165
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with SuperSonic Imagine. To contact SuperSonic Imagine, visit supersonicimagine.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SuperSonic Imagine compare?

A PDF of SuperSonic Imagine and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SuperSonic Imagine soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SuperSonic Imagine

SuperSonic Imagine is a French based company that specializes in ultrasound medical imaging. The company is known for its flagship product, the SuperSonic™ series, which incorporates the exclusive UltraFast™ technology. This technology has led to the development of pioneering imaging modes, particularly the ShearWave™ Elastography (SWE™), which allows physicians to assess tissue stiffness crucial in diagnosing various conditions. With over 600 published articles validating its diagnostic value, SuperSonic Imagine has garnered significant recognition. The company operates in over 80 countries and has experienced substantial growth in key markets such as China, the U.S., and the E.U. In December 2018, the company received a €12.00M Post-IPO Equity investment from Kreos Capital, signifying investor confidence and potential for further development. Notably, the Aixplorer MACH® 30 ultrasound diagnostic system and transducers hold significant certifications (CE certificate no. 26415, FDA cleared K180572) for a wide range of medical imaging applications. SuperSonic Imagine's commitment to innovation and its established presence in the global market position it as an intriguing prospect for potential investors.

Business keywords: Ultrasound Imaging, Elastography, Medical Diagnostics, Healthcare Innovation, Diagnostic Imaging, Medical Equipment, Tissue Elasticity, Women's Health, Liver Disease, Non-invasive Characterization, Vascular Imaging, Radiology, Clinical Research

Services & Products

Developing and providing advanced medical ultrasound technology and diagnostic imaging devices.

Target Customers

Healthcare providers medical professionals hospitals and diagnostic imaging centers.

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt €2.00M 1
Bpifrance
17 Dec 2018
Post IPO Equity €12.00M 1
Kreos Capital
17 Dec 2018
Venture Round €5.00M 1
Norginer Ventures
10 Jan 2014
Private Equity Round €28.00M 9
Omnes Capital, Auriga Partners +7
02 Apr 2013
Series C €34.50M 7
Omnes Capital, Auriga Partners +5
29 Nov 2010
Series B €20.00M 5
Omnes Capital, Auriga Partners +3
23 Oct 2008
Series A €10.00M 4
Omnes Capital, Auriga Partners +2
01 Mar 2006
Non Equity Assistance Undisclosed 1
Incubateur Impulse
05 Jun 2005

SuperSonic Imagine Alternatives & Competitors

View All Alternatives
SuperSonic Imagine vs

Creators of VELACUR: point-of-care AI guided ultrasound elastography for chronic liver diseases such...

Series A
41 employees
Health Care, Medical Devices
SuperSonic Imagine vs

Focused on early detection of liver disease

Post-IPO Equity
25 employees
Biotechnology, Health Care
SuperSonic Imagine vs
HepQuant, LLC
HepQuant, LLC United States

Transforming Liver Health

24 employees
Biotechnology, Health Care

FAQ About SuperSonic Imagine

Innovations in Ultrasound.
SuperSonic Imagine was founded in 2005.
SuperSonic Imagine is headquartered in France.
SuperSonic Imagine operates in Biotechnology, Health Care, Manufacturing and Medical Devices. Its work centres on Ultrasound Imaging, Elastography, Medical Diagnostics and Healthcare Innovation. Its customers include Healthcare providers, medical professionals and hospitals.
SuperSonic Imagine has approximately 165 employees.
SuperSonic Imagine has completed 8 funding rounds, raising a total of $111.50M. The latest funding stage is Post-IPO Equity.
SuperSonic Imagine offers: Developing and providing advanced medical ultrasound technology and diagnostic imaging devices..
Top alternatives and competitors to SuperSonic Imagine include Sonic Incytes Medical Corp., ENDRA Life Sciences (Nasdaq: NDRA), HepQuant, LLC, PIUR IMAGING GmbH, Hera-MI. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SuperSonic Imagine and Sonic Incytes Medical Corp. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SuperSonic Imagine, https://bouncewatch.com/company/supersonic-imagine, updated 11 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes